IBRN vs. IVV
IBRN (iShares Neuroscience and Healthcare ETF) and IVV (iShares Core S&P 500 ETF) are both exchange-traded funds - IBRN is a Health & Biotech Equities fund tracking the NYSE FactSet Global Neuro Biopharma and MedTech Index, while IVV is a S&P 500 fund tracking the S&P 500 Index. Both are passively managed. Over the past 3 years, IBRN returned 11.10%/yr vs 22.74%/yr for IVV. A 0.58 correlation means they provide meaningful diversification when combined. IBRN charges 0.47%/yr vs 0.03%/yr for IVV.
Performance
IBRN vs. IVV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBRN achieves a 4.62% return, which is significantly lower than IVV's 11.70% return.
IBRN
- 1D
- -4.52%
- 1M
- -1.90%
- YTD
- 4.62%
- 6M
- 12.73%
- 1Y
- 52.57%
- 3Y*
- 11.10%
- 5Y*
- —
- 10Y*
- —
IVV
- 1D
- 0.14%
- 1M
- 5.39%
- YTD
- 11.70%
- 6M
- 12.12%
- 1Y
- 29.71%
- 3Y*
- 22.74%
- 5Y*
- 14.26%
- 10Y*
- 15.62%
IBRN vs. IVV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
IBRN iShares Neuroscience and Healthcare ETF | 4.62% | 28.49% | -2.78% | 0.92% | 5.85% |
IVV iShares Core S&P 500 ETF | 11.70% | 17.85% | 24.93% | 26.31% | -4.77% |
Correlation
The correlation between IBRN and IVV is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.53 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Aug 29, 2022 | 0.58 |
The correlation between IBRN and IVV has been stable across timeframes, ranging from 0.53 to 0.58 - a consistent structural relationship.
IBRN vs. IVV - Sectors Allocation Comparison
Sectors
IBRN
IVV
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
IBRN
IVV
Basic Materials
IBRN
-
IVV
Communication Services
IBRN
-
IVV
Consumer Cyclical
IBRN
-
IVV
Consumer Defensive
IBRN
-
IVV
Energy
IBRN
-
IVV
Financial Services
IBRN
-
IVV
Industrials
IBRN
-
IVV
Real Estate
IBRN
-
IVV
Technology
IBRN
-
IVV
Utilities
IBRN
-
IVV
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBRN vs. IVV — Risk / Return Rank
IBRN
IVV
IBRN vs. IVV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBRN | IVV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.09 | 2.54 | -0.45 |
Sortino ratioReturn per unit of downside risk | 2.94 | 3.44 | -0.50 |
Omega ratioGain probability vs. loss probability | 1.34 | 1.46 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | 6.30 | 3.43 | +2.87 |
Martin ratioReturn relative to average drawdown | 15.59 | 15.97 | -0.37 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IBRN | IVV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.09 | 2.54 | -0.45 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.85 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.87 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.46 | -0.09 |
Drawdowns
IBRN vs. IVV - Drawdown Comparison
The maximum IBRN drawdown since its inception was -35.38%, smaller than the maximum IVV drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for IBRN and IVV.
Loading charts...
Drawdown Indicators
| IBRN | IVV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.38% | -55.25% | +19.87% |
Max Drawdown (1Y)Largest decline over 1 year | -8.80% | -8.89% | +0.09% |
Max Drawdown (3Y)Largest decline over 3 years | -35.38% | -18.75% | -16.63% |
Max Drawdown (5Y)Largest decline over 5 years | — | -24.53% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.90% | — |
Current DrawdownCurrent decline from peak | -6.28% | 0.00% | -6.28% |
Average DrawdownAverage peak-to-trough decline | -9.83% | -10.78% | +0.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.56% | 1.91% | +1.65% |
Volatility
IBRN vs. IVV - Volatility Comparison
iShares Neuroscience and Healthcare ETF (IBRN) has a higher volatility of 7.66% compared to iShares Core S&P 500 ETF (IVV) at 2.75%. This indicates that IBRN's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBRN | IVV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.66% | 2.75% | +4.91% |
Volatility (6M)Calculated over the trailing 6-month period | 19.29% | 8.87% | +10.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.38% | 11.78% | +13.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.32% | 16.88% | +8.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.32% | 18.05% | +7.27% |
IBRN vs. IVV - Expense Ratio Comparison
IBRN has a 0.47% expense ratio, which is higher than IVV's 0.03% expense ratio.
Dividends
IBRN vs. IVV - Dividend Comparison
IBRN's dividend yield for the trailing twelve months is around 0.95%, less than IVV's 1.06% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBRN iShares Neuroscience and Healthcare ETF | 0.95% | 0.99% | 0.40% | 0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IVV iShares Core S&P 500 ETF | 1.06% | 1.17% | 1.30% | 1.44% | 1.66% | 1.20% | 1.57% | 1.85% | 2.21% | 1.75% | 2.01% | 2.27% |
Frequently Asked Questions
IBRN and IVV have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBRN has higher volatility (7.66%) compared to IVV (2.75%). In terms of maximum drawdown, IBRN dropped -35.38% vs IVV's -55.25%.
On 3-year performance, IVV leads with 22.74% vs 11.10% for IBRN. On fees, IVV is cheaper at 0.03% per year. On volatility, IVV has been the lower-risk option at 2.75%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IVV has performed better with a 22.74% return vs 11.10%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IVV is cheaper with a 0.03% expense ratio, compared with 0.47% for IBRN.
IVV has the higher dividend yield at 1.06%, compared with 0.95% for IBRN.
IBRN is categorized as Health & Biotech Equities, while IVV is S&P 500. IBRN tracks NYSE FactSet Global Neuro Biopharma and MedTech Index, while IVV tracks S&P 500 Index. Their fees differ too: 0.47% for IBRN and 0.03% for IVV.
IVV currently has the higher Sharpe Ratio (2.54 vs 2.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBRN and IVV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer